Diana Campos

Diana Campos is a Postdoctoral Researcher at the Max Planck Institute for Heart and Lung Research since February 2022, with extensive experience in molecular oncology and glycobiology. Diana's research interests focus on specific glycosylation changes that lead to the conversion of wild-type proteins into cancer-specific antigens, with a particular emphasis on their role in the progression of aggressive prostate cancer. Previous positions include Junior Researcher and Postdoctoral Fellow at i3S - Instituto de Investigação e Inovação em Saúde and Georgetown University, respectively. Diana holds a Ph.D. in Biomedicine from the University of Porto and Copenhagen Center for Glycomics, a Master’s Degree in Molecular Oncology, and a Bachelor's Degree in Biochemistry from the University of Porto.